The use of the Xience nanoTM coronary stent system for the treatment of small vessels coronary artery disease
نویسنده
چکیده
Drug-eluting stents have proven long-term safety and effectiveness for the treatment of coronary artery disease especially due to their marked efficacy in reducing restenosis rates. Nevertheless, the rates of late and very late stent thrombosis, especially in first-generation systems, have raised some concerns. Moreover, percutaneous coronary intervention to small vessels (especially <2.5 mm) remains challenging. The Xience nanoTM drug-eluting stent system was developed to improve coronary luminal diameter in patients with symptomatic heart disease due to de novo native coronary artery lesions (length ≤28 mm) with reference vessel diameters of ≥2.25 to <2.50 mm. In this article, we describe the components of the Xience nano drug-eluting stent system presenting clinical data of this current stent.
منابع مشابه
Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials.
OBJECTIVES The aim of this study was to investigate the impact of reference vessel diameter (RVD) and lesion length (LL) on the relative safety and efficacy of everolimus-eluting stents (EES) and paclitaxel-eluting stents (PES). BACKGROUND Lesion length and RVD are well-known predictors of adverse events after percutaneous coronary intervention. METHODS Patient-level data were pooled from t...
متن کاملAcute and Long Term Outcomes of Coronary Intervention in Unprotected Left Main Lesions
Introduction : Significant left main coronary artery stenosis jeopardizes the entire myocardium of the left ventricle and has the worst prognosis of any form of coronary artery disease. Coronary-artery bypass grafting (CABG) has been considered as the standard therapeutic approach for such patients. There are limited data on the safety and effectiveness of percutaneous coronary intervention (PC...
متن کاملOverview of Intracoronary Brachytherapy for in-Stent Restenosis of a Drug-Eluting Stent
Percutaneous coronary intervention with stenting is considered recently as the most common procedure for the treatment of symptomatic coronary. The article reviewed 41 studies published during 1997-2019 on intracoronary brachytherapy for in-stent restenosis of a drug-eluting stent. Intracoronary radiation therapy was finally confirmed in the setting of in-stent restenosis using as adjunctive th...
متن کاملNext-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V®)
Percutaneous coronary revascularization has been a mainstay in the management of coronary artery disease since its introduction in the late 1970s. Bare-metal stents and, more recently, first-generation drug-eluting stents (DES), such as sirolimus-eluting (Cypher) and paclitaxel-eluting stents (Taxus), have further improved results of percutaneous coronary intervention (PCI) by improving early r...
متن کاملManagement of a large coronary artery aneurysm with graft-coated stent during the acute phase of myocardial infarction
Coronary aneurysms in adults are rare clinical entities. Herein, we presented a 54-year-old man who was admitted with an acute extensive anterior myocardial infarction. The emergency coronary angiography revealed an isolated large aneurysm at the proximal segment of the left anterior descending coronary artery. The patient was successfully treated with a graft-coated stent
متن کامل